-+ 0.00%
-+ 0.00%
-+ 0.00%

Phio Pharmaceuticals Receives Nasdaq Notice Over Minimum Bid Price Noncompliance

PUBT·11/20/2026 21:10:25
Phio Pharmaceuticals Receives Nasdaq Notice Over Minimum Bid Price Noncompliance
  • Phio Pharmaceuticals received a Nasdaq noncompliance notice on November 16, 2026, for breaching the $1 minimum bid price requirement.
  • Its common stock closed below $1 for 30 consecutive business days. The notice has no immediate effect on listing or trading.
  • Nasdaq granted an initial 180-calendar-day period, until May 17, 2027, to regain compliance.
  • Compliance requires a closing bid price of at least $1 for at least 10 consecutive business days before the deadline.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-037895), on November 20, 2026, and is solely responsible for the information contained therein.